IMCD, NL0010801007

IMCD N.V. stock (NL0010801007): stable Amsterdam trading ahead of next earnings update

29.05.2026 - 15:32:22 | ad-hoc-news.de

IMCD N.V. shares traded slightly lower on Euronext Amsterdam on 05/29/2026, with the Dutch specialty chemicals distributor moving in line with a subdued broader market while investors wait for the next earnings catalysts and reassess valuation metrics.

IMCD, NL0010801007
IMCD, NL0010801007

IMCD N.V. shares were moderately softer in Friday trading on Euronext Amsterdam, with the stock quoted at around EUR 88-90 during the afternoon session on 05/29/2026, according to live pricing data from Euronext and trading overviews that show the name as part of the Dutch mid- to large-cap universe.

The Netherlands-based specialty chemicals and ingredients distributor continues to draw interest from investors on its home market as they weigh its recent operational performance, acquisition strategy and cash generation against the current valuation multiples implied by the share price.

The stock traded around EUR 89 on Euronext Amsterdam on 05/29/2026, according to Investing.com data referencing the IMCD line under the Netherlands equities section.

As of: 05/29/2026

By the editorial team - specialized in equity coverage.

At a glance

  • Name: IMCD
  • Sector/industry: Specialty chemicals distribution and formulation services
  • Headquarters/country: Rotterdam, Netherlands
  • Core markets: Europe, Americas, Asia-Pacific, Middle East and Africa
  • Key revenue drivers: Distribution of specialty chemicals and food, pharmaceutical and industrial ingredients, technical and formulation support, and value-added application development
  • Home exchange/listing venue: Euronext Amsterdam (IMCD)
  • Trading currency: EUR

IMCD N.V.: core business model

IMCD operates as a global distributor and formulation partner for specialty chemicals and ingredients, generating revenue by connecting suppliers and industrial customers while offering technical application support across end-markets such as pharmaceuticals, food, personal care and advanced industrial applications.

Valuation metrics and multiples for IMCD N.V.

With IMCD N.V. trading in the high-EUR 80s on 05/29/2026, investors in the Netherlands and abroad are focusing on how the current capitalization reflects the company’s earnings power, free cash flow profile and balance between organic growth and acquisitions, especially after several years of expansion in multiple regions.

Market data providers and broker overviews indicate that IMCD is typically valued using earnings-based multiples such as price-to-earnings and enterprise-value-to-EBITDA, alongside cash flow measures, although the precise ratios fluctuate with the share price and updated financial results that the company reports on its investor relations platform.

Read more

Additional news and developments on the stock can be explored via the linked overview pages.

More news on this stockInvestor relations

Sentiment and reactions on IMCD N.V.

The modest move in IMCD N.V. on Euronext Amsterdam on 05/29/2026 is drawing interest from market watchers who discuss the stock’s valuation and growth outlook across social and video platforms.

YouTubeXTikTokInstagram

Conclusion

IMCD N.V. shares were slightly lower on Euronext Amsterdam on 05/29/2026, reflecting a calm trading session in the Dutch market as investors look ahead to the company’s next set of financial disclosures.

The current share price in the high-EUR 80s keeps attention on how the distributor’s earnings trajectory and cash flows line up with its valuation multiples, particularly given its acquisitive track record and geographic diversification.

For now, the stock remains a liquid Netherlands listing that continues to feature in discussions about specialty chemicals distribution and the broader European mid-cap universe.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.

So schätzen die Börsenprofis IMCD Aktien ein!

<b>So schätzen die Börsenprofis IMCD Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | NL0010801007 | IMCD | boerse | 69442050 | bgmi